完整回顾：首届全球医美科技大会

Core Viewpoint - The first Global Aesthetic Technology Conference 2025 was held in Beijing, focusing on the deep development of aesthetic technology and the efficient gathering of innovative resources, signaling a new stage of systematic innovation and implementation capability in China's aesthetic technology sector [2][14]. Group 1: Policy Guidance and Mechanism Construction - The conference established a main theme of "starting from demand and focusing on transformation," with significant policy support for the aesthetic medicine sector in Beijing [3][14]. - A series of policy tools have been introduced in the "beautiful health" field, forming a systematic ecosystem in terms of industrial space, funding support, talent cultivation, and service mechanisms [3][14]. Group 2: Multidisciplinary Collaboration - The integration of regenerative medicine, material science, energy devices, and artificial intelligence is emphasized as the core of advancing aesthetic technology [5][14]. - Collagen-related products are highlighted as current clinical and industrial hotspots, reflecting a consensus in the industry to move upstream and closer to clinical applications [5][14]. Group 3: Awards and Competitions - The conference launched the 2025 Global Aesthetic Technology Innovation Awards, showcasing innovations in materials, equipment, and results transformation within the aesthetic technology sector [7][14]. - The third China Aesthetic Surgery Technology Achievement Transformation Competition was initiated, focusing on the core role of aesthetic surgery technology achievements in industry development [9][14]. Group 4: Systematic Challenges in Aesthetic Technology - The aesthetic industry is undergoing a reconstruction led by science, with challenges in regulatory evaluation and intellectual property becoming key variables for success [15][26]. - Experts discussed the need for a collaborative system to overcome challenges in the transition from research to clinical application, emphasizing the importance of synchronized efforts across science, regulation, clinical practice, and market dynamics [26][39]. Group 5: Pathway Design and Investment Insights - Investors are advised to focus on the ability of technology to complete the closed loop from research and development to sales, with an emphasis on the importance of understanding consumer needs [30][32]. - The transition from laboratory to clinical application faces numerous barriers, including ethical approvals and product registration, which require a systematic understanding of regulatory frameworks [32][33]. - The need for independent product definitions and development standards in aesthetic applications is highlighted, as materials from other medical fields cannot be directly transferred without adaptation [36][39]. Group 6: Knowledge and Intellectual Property Awareness - There is a common oversight among researchers regarding the importance of intellectual property, with many prioritizing publication over patent protection, which can lead to loss of core technology [38][39]. - The consensus among industry experts is that a clear understanding of patent strategies and regulatory frameworks is essential for the successful transformation of research outcomes into marketable products [38][39].